SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-046800
Filing Date
2023-06-06
Accepted
2023-06-06 16:22:03
Documents
13
Period of Report
2023-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea179856-8k_dominari.htm   iXBRL 8-K 23604
  Complete submission text file 0001213900-23-046800.txt   222894

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE domh-20230605.xsd EX-101.SCH 2971
3 XBRL DEFINITION FILE domh-20230605_def.xml EX-101.DEF 26198
4 XBRL LABEL FILE domh-20230605_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE domh-20230605_pre.xml EX-101.PRE 22367
7 EXTRACTED XBRL INSTANCE DOCUMENT ea179856-8k_dominari_htm.xml XML 3590
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Dominari Holdings Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-05576 | Film No.: 23996373
SIC: 2834 Pharmaceutical Preparations